文献速递消化道肿瘤与早癌消化内镜

FIT阳性后未行结肠镜检查使结直肠癌死亡风险翻倍

Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.
PubMed 文献 · Gut · 2021-03-31

结果显示未依从者结直肠癌死亡风险增加103%(调整HR 2.03,95%CI 1.68-2.44),提示应针对该高危人群采取干预提高依从性。

要点

  • FIT阳性未行结肠镜者10年结直肠癌累积死亡率为16.0/1000,完成者为6.8/1000
  • 未依从者结直肠癌死亡风险较依从者高103%(调整HR 2.03,95%CI 1.68-2.44)
  • 筛查项目应采取措施提高FIT阳性人群的结肠镜依从性

核心结论

  • FIT阳性后未完成结肠镜检查与结直肠癌死亡风险增加独立相关,调整HR为2.03(95%CI 1.68-2.44)。

研究设计与样本

  • 回顾性队列研究,纳入意大利威尼托地区FIT结直肠癌筛查项目中50至69岁、FIT阳性(>20 µg Hb/g粪便)并受邀至内镜转诊中心行诊断性结肠镜检查者。
  • 采用Kaplan-Meier估计法和Cox-Aalen模型比较两组10年累积结直肠癌发病率和死亡率。

主要发现

  • 完成结肠镜者10年结直肠癌累积发病率为44.7/1000(95%CI 43.1-46.3),未完成者为54.3/1000(95%CI 49.9-58.7)。
  • 完成结肠镜者10年结直肠癌累积死亡率为6.8/1000(95%CI 5.9-7.6),未完成者为16.0/1000(95%CI 13.1-18.9)。
  • 未完成结肠镜者结直肠癌死亡风险较完成者高103%(调整HR 2.03,95%CI 1.68-2.44)。

临床怎么用

  • 对FIT阳性者应积极促进结肠镜转诊与完成,将其作为筛查项目质量改进的优先目标。
  • 临床沟通中可告知FIT阳性未行结肠镜者其结直肠癌死亡风险显著升高,以增强依从动机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of colorectal cancer (CRC) among subjects with a positive faecal immunochemical test (FIT) who do not undergo a colonoscopy is unknown. We estimated whether non-compliance with colonoscopy after a positive FIT is associated with increased CRC incidence and mortality. METHODS: The FIT-based CRC screening programme in the Veneto region (Italy) invited persons aged 50 to 69 years with a positive FIT (>20 µg Hb/g faeces) for diagnostic colonoscopy at an endoscopic referral centre. In this retrospective cohort study, we compared the 10-year cumulative CRC incidence and mortality among FIT positives who completed a diagnostic colonoscopy within the programme (compliers) and those who did not (non-compliers), using the Kaplan-Meier estimator and Cox-Aalen models. RESULTS: Some 88 013 patients who were FIT positive complied with colonoscopy (males: 56.1%; aged 50-59 years: 49.1%) while 23 410 did not (males: 54.6%; aged 50-59 years: 44.9%).The 10-year cumulative incidence of CRC was 44.7 per 1000 (95% CI, 43.1 to 46.3) among colonoscopy compliers and 54.3 per 1000 (95% CI, 49.9 to 58.7) in non-compliers, while the cumulative mortality for CRC was 6.8 per 1000 (95% CI, 5.9 to 7.6) and 16.0 per 1000 (95% CI, 13.1 to 18.9), respectively. The risk of dying of CRC among non-compliers was 103% higher than among compliers (adjusted HR, 2.03; 95% CI, 1.68 to 2.44). CONCLUSION: The excess risk of CRC death among those not completing colonoscopy after a positive faecal occult blood test should prompt screening programmes to adopt effective interventions to increase compliance in this high-risk population.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Zorzi M, Battagello J, Selby K, et al. Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer. Gut. 2021. PMID: 33789965. doi:10.1136/gutjnl-2020-322192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。